Treatment of a severely bleeding patient without preexisting coagulopathy with activated recombinant factor VII

被引：65
作者：
Vlot, AJ
Ton, E
Mackaay, AJC
Kramer, MHH
Gaillard, CAJM [1 ]
机构：
[1] Eemland Hosp, Dept Internal Med, NL-3818 ES Amersfoort, Netherlands
[2] Eemland Hosp, Dept Surg, NL-3818 ES Amersfoort, Netherlands
来源：
AMERICAN JOURNAL OF MEDICINE | 2000年 / 108卷 / 05期
关键词：
D O I：
10.1016/S0002-9343(99)00398-8
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：421 / 423
页数：3
相关论文
共 9 条
  • [1] HEDNER U, 1988, LANCET, V2, P1193
  • [2] Kristensen J, 1996, HAEMOSTASIS, V26, P159
  • [3] MEDICAL PROGRESS - BLEEDING PEPTIC-ULCER
    LAINE, L
    PETERSON, WL
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1994, 331 (11) : 717 - 727
  • [4] Lusher JM, 1996, HAEMOSTASIS, V26, P124
  • [5] Meijer K, 1998, THROMB HAEMOSTASIS, V80, P204
  • [6] Peters M, 1998, THROMB HAEMOSTASIS, V80, P352
  • [7] RAPAPORT SI, 1995, THROMB HAEMOSTASIS, V74, P7
  • [8] THE ACTIVATION OF FACTOR-X AND PROTHROMBIN BY RECOMBINANT FACTOR VIIA IN-VIVO IS MEDIATED BY TISSUE FACTOR
    TENCATE, H
    BAUER, KA
    LEVI, M
    EDGINGTON, TS
    SUBLETT, RD
    BARZEGAR, S
    KASS, BL
    ROSENBERG, RD
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1993, 92 (03) : 1207 - 1212
  • [9] Tengborn L, 1996, THROMB HAEMOSTASIS, V75, P981
1